Literature DB >> 6352100

Human monocytes have prothrombin cleaving activity.

N Hogg.   

Abstract

A proportion of human monocytes form long needles of fibrin on their surfaces when they are briefly exposed to human plasma. A number of coagulation factor deficient plasmas (II, V, VII, VIII, von Willebrand, IX, X, XI and XII) were tested for their ability to promote formation of this fibrin. Monocytes failed to make fibrin only in Factor II or prothrombin deficient plasma. Thrombin is involved in the manufacture of monocyte fibrin as shown by the ability of the thrombin specific inhibitor, hirudin, to block the process and by the demonstration that monocytes are able to cleave prothrombin to thrombin, an activity which increases with time of monocyte incubation at 37 degrees C. These results indicate that human monocytes possess a prothrombin cleaving activity although it remains unclear how this activity is generated. It is speculated that thrombin serves a necessary role in both wound healing and tissue repair.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352100      PMCID: PMC1535641     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Enhancement of monocyte thromboplastin activity by antigenically stimulated lymphocytes: a link between immune reactivity and blood coagulation.

Authors:  C J van Ginkel; W P Zeijlemaker; L A Stricker; J I Oh; W G van Aken
Journal:  Eur J Immunol       Date:  1981-07       Impact factor: 5.532

2.  A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages on vivo.

Authors:  K E Hopper; C L Geczy; W A Davies
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

3.  Sequential appearance of fibronectin and collagen in experimental granulation tissue.

Authors:  M Kurkinen; A Vaheri; P J Roberts; S Stenman
Journal:  Lab Invest       Date:  1980-07       Impact factor: 5.662

Review 4.  Blood coagulation.

Authors:  C M Jackson; Y Nemerson
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

5.  Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells.

Authors:  B S Schwartz; G A Levy; L K Curtiss; D S Fair; T S Edgington
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

6.  Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro.

Authors:  B Osterud; J Bögwald; U Lindahl; R Seljelid
Journal:  FEBS Lett       Date:  1981-05-05       Impact factor: 4.124

7.  Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages.

Authors:  U Lindahl; S O Kolset; J Bøgwald; B Osterud; R Seljelid
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

8.  Binding of human factor VII and VIIa to monocytes.

Authors:  G J Broze
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

9.  Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase.

Authors:  B S Schwartz; G A Levy; D S Fair; T S Edgington
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

10.  Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.

Authors:  G A Levy; J L Leibowitz; T S Edgington
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  9 in total

1.  Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer.

Authors:  Takashi Suzuki; Hideaki Shimada; Tatsuki Nanami; Yoko Oshima; Satoshi Yajima; Masaaki Ito; Naohiro Washizawa; Hironori Kaneko
Journal:  Surg Today       Date:  2016-05-09       Impact factor: 2.549

2.  Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma.

Authors:  Takashi Suzuki; Hideaki Shimada; Tatsuki Nanami; Yoko Oshima; Satoshi Yajima; Naohiro Washizawa; Hironori Kaneko
Journal:  Int J Clin Oncol       Date:  2017-01-07       Impact factor: 3.402

3.  Absence of monocyte procoagulant activity during the immune response to influenza virus.

Authors:  M Mathies; N Hogg
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

4.  Pseudo-leptospires in broncho-alveolar lavage fluid and blood cell cultures.

Authors:  W R Williams; B H Davies
Journal:  Br J Exp Pathol       Date:  1986-04

5.  Effect of cyclosporine A on procoagulant activity in mononuclear blood cells and monocytes in vitro.

Authors:  E Carlsen; A C Mallet; H Prydz
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

6.  Thrombin and factor Xa enhance the production of interleukin-1.

Authors:  A Jones; C L Geczy
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

Review 7.  The role of lymphokines in delayed-type hypersensitivity reactions.

Authors:  C L Geczy
Journal:  Springer Semin Immunopathol       Date:  1984

8.  Accumulation of anthracotic particles along lymphatics of the human lung: relevance to "hot spot" formation after inhalation of poorly soluble radionuclides.

Authors:  H Cottier; F Meister; A Zimmermann; R Kraft; A Burkhardt; P Gehr; G Poretti
Journal:  Radiat Environ Biophys       Date:  1987       Impact factor: 1.925

9.  Bradykinin stimulates bone resorption and lysosomal-enzyme release in cultured mouse calvaria.

Authors:  G T Gustafson; U Lerner
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.